Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-12-12)Premium Content

Alkermes Plc (ALKS)

2014-12-18@02:00:47 ET
Alkermes Commences Clinical Study of Aripiprazole Lauroxil (CLM)

2014-12-17@04:10:41 ET
Alkermes initiates Phase I schizophrenia study (DTM)

2014-12-15@13:57:53 ET
Shares of Alkermes Under Pressure, Down 3.0% (F77)

2014-12-15@09:10:06 ET
Alkermes (ALKS) Showing Bullish Technicals With Support At $53.44 (FBM)

2014-12-15@07:00:04 ET
Alkermes Announces Initiation of Clinical Study of Extended Durations of Aripiprazole Lauroxil for Treatment of Schizophrenia (BIZ)

2014-12-12@08:41:45 ET
Form 4: Update Filing for Alkermes PLC (ALKS) (VKR)

2014-12-12@08:41:35 ET
Form 4: Update Filing for Alkermes PLC (ALKS) (VKR)

2014-12-12@08:41:25 ET
Form 4: Update Filing for Alkermes PLC (ALKS) (VKR)

2014-12-12@08:41:14 ET
Form 4: Update Filing for Alkermes PLC (ALKS) (VKR)

2014-12-11@11:23:24 ET
Uptrend Call Working As Alkermes Stock Rises 29.1% (ALKS) (PSM)

2014-12-11@05:05:35 ET
Form 144: Filing to Sell 5000 Shares of Alkermes PLC (ALKS) (VKR)

2014-12-10@12:23:22 ET
Alkermes Bearish Moving Average Crossover Alert (ALKS) (F78)

2014-12-10@08:12:13 ET
Analysis of Relative Performance in the Biotechnology Industry for Shares of Cubist Pharmaceuticals (CBST, ALKS, MDVN, AMGN, REGN) (F70)

2014-12-09@15:40:56 ET
Alkermes (ALKS) Showing Resistance Near $60.57 (FBM)

2014-12-08@16:43:36 ET
Recent 52-Week High Exceeded in Shares of Alkermes (ALKS) (F71)